KALA BIO, Inc.
KALA
$2.93
-$0.16-5.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 109.07% | 32.19% | -24.68% | -9.44% | 8.66% |
| Total Depreciation and Amortization | -57.81% | 91.04% | -1.47% | -1.45% | 9.52% |
| Total Amortization of Deferred Charges | -1,084.48% | -32.95% | -6.99% | -37.79% | -7.14% |
| Total Other Non-Cash Items | -115.76% | -151.55% | 2.73% | 11.00% | -14.57% |
| Change in Net Operating Assets | 38.99% | -427.81% | 127.19% | -348.25% | -20.12% |
| Cash from Operations | 58.11% | -40.64% | 12.35% | -91.91% | 2.69% |
| Capital Expenditure | -100.00% | 106.25% | -- | -- | 23.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -100.00% | 106.25% | -- | -- | 23.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -66,290.00% | 98.81% | -8,935.71% | 99.44% | -27,827.78% |
| Issuance of Common Stock | 15,123.33% | -- | -100.00% | -99.89% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Financing | -30,043.33% | 101.19% | -1,774.07% | -102.03% | 3,792.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -24.83% | -5.51% | -14.74% | -552.70% | 139.62% |